Pattern Visually Evoked Potentials (pVEPs) and Retinal Nerve Fiber Thickness in a Japanese Girl With Anti-myelin Oligodendrocyte Glycoprotein Antibody Seropositive Optic Neuritis

Midori Tachibana; Shunichiro Takano; Yuri Ohta; Kei Shinoda; Hideo Yamanouchi

doi:10.7759/cureus.65254

journal article Jul 24, 2024

Pattern Visually Evoked Potentials (pVEPs) and Retinal Nerve Fiber Thickness in a Japanese Girl With Anti-myelin Oligodendrocyte Glycoprotein Antibody Seropositive Optic Neuritis

Midori Tachibana Shunichiro Takano Yuri Ohta Kei Shinoda Hideo Yamanouchi

Cureus · Springer Science and Business Media LLC

View at Publisher Save 10.7759/cureus.65254

Topics

No keywords indexed for this article. Browse by subject →

References

21

[1]

Jarius S, Paul F, Aktas O, et al.. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018, 15:134. 10.1186/s12974-018-1144-2 10.1186/s12974-018-1144-2

[2]

Cobo-Calvo A, Ruiz A, Maillart E, et al.. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study. Neurology. 2018, 90:e1858-69. 10.1212/WNL.0000000000005560 10.1212/wnl.0000000000005560

[3]

Jarius S, Ruprecht K, Kleiter I, et al.. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation. 2016, 13:280. 10.1186/s12974-016-0718-0 10.1186/s12974-016-0718-0

[4]

Havla J, Pakeerathan T, Schwake C, et al.. Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?. J Neuroinflammation. 2021, 18:121. 10.1186/s12974-021-02160-9 10.1186/s12974-021-02160-9

[5]

Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

Alvaro Cobo‐Calvo, Anne Ruiz, Fabien Rollot et al.

Annals of Neurology 2021 10.1002/ana.25909

[6]

Takano S, Hanabusa A, Yoshikawa Y, et al.. Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody. Front Neurol. 2019, 10:1339. 10.3389/fneur.2019.01339 10.3389/fneur.2019.01339

[7]

Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes

Patrick Waters, Giulia Fadda, Mark Woodhall et al.

JAMA Neurology 2020 10.1001/jamaneurol.2019.2940

[8]

Gericke FC, Hanson JV, Hackenberg A, Gerth-Kahlert C. Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Eur J Paediatr Neurol. 2024, 48:113-20. 10.1016/j.ejpn.2023.12.006 10.1016/j.ejpn.2023.12.006

[9]

Oertel FC, Sotirchos ES, Zimmermann HG, et al.. Longitudinal retinal changes in MOGAD. Ann Neurol. 2022, 92:476-85. 10.1002/ana.26440 10.1002/ana.26440

[10]

Pakeerathan T, Havla J, Schwake C, et al.. Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode. J Neurol. 2022, 269:6366-76. 10.1007/s00415-022-11256-y 10.1007/s00415-022-11256-y

[11]

Akaishi T, Himori N, Takeshita T, et al.. Follow-up of retinal thickness and optic MRI after optic neuritis in anti-MOG antibody-associated disease and anti-AQP4 antibody-positive NMOSD. J Neurol Sci. 2022, 437:120269. 10.1016/j.jns.2022.120269 10.1016/j.jns.2022.120269

[12]

Aytulun A, Cruz-Herranz A, Aktas O, et al.. APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies. Neurology. 2021, 97:68-79. 10.1212/WNL.0000000000012125 10.1212/wnl.0000000000012125

[13]

Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A, Tormene AP. ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol. 2016, 133:1-9. 10.1007/s10633-016-9553-y 10.1007/s10633-016-9553-y

[14]

Vabanesi M, Pisa M, Guerrieri S, et al.. In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis. Sci Rep. 2019, 9:10371. 10.1038/s41598-019-46251-3 10.1038/s41598-019-46251-3

[15]

Watanabe A, Matsushita T, Doi H, et al.. Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients. J Neurol Sci. 2009, 281:34-40. 10.1016/j.jns.2009.02.371 10.1016/j.jns.2009.02.371

[16]

Marignier R, Hacohen Y, Cobo-Calvo A, et al.. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021, 20:762-72. 10.1016/S1474-4422(21)00218-0 10.1016/s1474-4422(21)00218-0

[17]

Song H, Zhou H, Yang M, Xu Q, Sun M, Wei S. Clinical characteristics and outcomes of myelin oligodendrocyte glycoprotein antibody-seropositive optic neuritis in varying age groups: a cohort study in China. J Neurol Sci. 2019, 400:83-9. 10.1016/j.jns.2019.03.014 10.1016/j.jns.2019.03.014

[18]

Liu R, Zhou J, Zhao H, Dai Y, Zhang Y, Tang Y, Zhou Y. Immature visual neural system in children reflected by contrast sensitivity with adaptive optics correction. Sci Rep. 2014, 4:4687. 10.1038/srep04687 10.1038/srep04687

[19]

Jenkins TM, Toosy AT, Ciccarelli O, et al.. Neuroplasticity predicts outcome of optic neuritis independent of tissue damage. Ann Neurol. 2010, 67:99-113. 10.1002/ana.21823 10.1002/ana.21823

[20]

Costello F, Hodge W, Pan YI, Eggenberger E, Coupland S, Kardon RH. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Mult Scler. 2008, 14:893-905. 10.1177/1352458508091367 10.1177/1352458508091367

[21]

Kupersmith MJ, Garvin MK, Wang JK, Durbin M, Kardon R. Retinal ganglion cell layer thinning within one month of presentation for non-arteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2016, 57:3588-93. 10.1167/iovs.15-18736 10.1167/iovs.15-18736

Metrics

0

Citations

21

References

Details

Published: Jul 24, 2024

Authors

Cite This Article

Midori Tachibana, Shunichiro Takano, Yuri Ohta, et al. (2024). Pattern Visually Evoked Potentials (pVEPs) and Retinal Nerve Fiber Thickness in a Japanese Girl With Anti-myelin Oligodendrocyte Glycoprotein Antibody Seropositive Optic Neuritis. Cureus. https://doi.org/10.7759/cureus.65254

Pattern Visually Evoked Potentials (pVEPs) and Retinal Nerve Fiber Thickness in a Japanese Girl With Anti-myelin Oligodendrocyte Glycoprotein Antibody Seropositive Optic Neuritis

You May Also Like